Type 1 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have previously taken part in a type 1 diabetes study that was approved by the Immune Tolerance Network (ITN) executive committee.
- People who are able to sign a consent form agreeing to take part (for children, a parent or guardian may sign on their behalf, with the child's agreement where appropriate).
Who may not be able to join:
- People who have a medical condition that the lead doctor believes could make it unsafe for them to complete the trial.
- People who are unable to attend the required study visits or complete the required assessments.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Beta Cell Function by MMTT-Stimulated Mean C-peptide Area Under the Curve (AUC)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.